The Safety and Efficacy Assessment of Cosmetic Products Containing Assam Tea Extracts in Volunteers.
The Effect of Cosmetic Products Containing Assam Tea (Camellia Sinensis Var. Assamica) Extracts on Irritation, Moisturization, Skin Elasticity, Wrinkles, and Satisfaction in Volunteers.
1 other identifier
interventional
60
1 country
1
Brief Summary
Thailand has entered an aging society, prompting increased research on improving the elderly quality of life and preventing age-related diseases, with a particular focus on skin aging. Skin aging is linked to the degradation of dermal and epidermal tissue, leading to decreased collagen, elastin, and glycosaminoglycans, which causes reduced skin elasticity and wrinkles. Assam tea is native to northern Thailand and is traditionally used in local products like fermented "Miang." Research shows that Assam tea contains high levels of polyphenols, particularly catechins, which have strong antioxidant properties that help combat conditions such as cancer, cardiovascular disease, and skin aging. The study aims to study the effect of cosmetic products from Assam tea on irritation, moisturization, skin elasticity, wrinkles, and satisfaction in volunteers to enhance its value, particularly for the elderly. This effort is intended to boost the local economy, promote community-based tourism, and expand Assam tea products to national and international markets, ultimately improving livelihoods and addressing environmental concerns in northern Thailand.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy-volunteers
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedFirst Submitted
Initial submission to the registry
October 3, 2024
CompletedFirst Posted
Study publicly available on registry
October 8, 2024
CompletedOctober 8, 2024
October 1, 2024
7 months
October 3, 2024
October 7, 2024
Conditions
Outcome Measures
Primary Outcomes (6)
Skin hydration
Measure skin hydration by using a Corneometer®
2 months
Transepidermal water loss (TEWL)
Measure TEWL by using a Tewameter®
2 months
Skin irritation
Evaluate redness and edema occurred after applying the tested products by closed patch test under occlusion with Finn chamber®
2 months
Values from Cutometer®
Such as R0, R1, R2, R3, R4, R5, R6, R7, R8, R9
2 months
Values from Skin-Visiometer®
Such as Volume, Surface, SEr, SEsc, SEsm, SEw
2 months
Sensory evaluation
Measure the parameters such as color, odor, viscosity, texture, etc using labeled affective magnitude scale
2 months
Study Arms (2)
Volunteers who recieved tested product
EXPERIMENTALVolunteers who recieved tested product
Volunteers who recieved base product
PLACEBO COMPARATORVolunteers who recieved base product
Interventions
Cosmetic products containing 0% Assam tea
Cosmetic products containing 2.5% Assam tea
Eligibility Criteria
You may qualify if:
- Aged 35 years and older
- Good physical and mental health
- Willing and able to provide informed consent to participate and complete the entire duration of the study
You may not qualify if:
- Women who are pregnant or breastfeeding
- Presence of existing dermatological conditions
- History of autoimmune disorders
- Prior use of products related to wrinkle reduction or those containing active ingredients that stimulate collagen or elastin production, including topical and oral products used within the past three months (e.g., coenzyme Q10, marine extracts, pine bark extract, glutathione, and vitamin C)
- Participation in any other volunteer study or program within the past three months
- Use of the following medications within the past three months: contraceptives, phenytoin, hydantoin, levodopa, chloroquine, cancer chemotherapy drugs, or medications containing heavy metals
- History of receiving dermatological or cosmetic procedures such as IPL (Intense Pulse Light) laser, phonophoresis, iontophoresis, laser treatments, Botox injections, fillers, or stem cell injections
- Volunteers who exhibit sensitivity or irritation to the test products used in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Cosmetic Science, Mae Fah Luang University
Mueang, Changwat Chiang Rai, 57100, Thailand
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 3, 2024
First Posted
October 8, 2024
Study Start
March 17, 2024
Primary Completion
September 30, 2024
Study Completion
September 30, 2024
Last Updated
October 8, 2024
Record last verified: 2024-10